140 related articles for article (PubMed ID: 38762488)
1. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
[TBL] [Abstract][Full Text] [Related]
2. Long-term re-intervention after USgHIFU and prediction of NPVR in different ages of patients with uterine fibroids.
Li S; Ma WW; Yang MJ; Deng YB; Hu L; Chen JY
Int J Hyperthermia; 2024; 41(1):2304264. PubMed ID: 38258583
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: a multicentre study.
Gong X; Zhang X; Liu D; Yang C; Zhang R; Xiao Z; Chen W; Chen J
J Int Med Res; 2022 May; 50(5):3000605221102087. PubMed ID: 35634930
[TBL] [Abstract][Full Text] [Related]
4. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis.
Dou Y; Zhang L; Liu Y; He M; Wang Y; Wang Z
Int J Hyperthermia; 2024; 41(1):2299479. PubMed ID: 38164630
[TBL] [Abstract][Full Text] [Related]
6. A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.
Yang MJ; Yu RQ; Chen WZ; Chen JY; Wang ZB
Front Surg; 2021; 8():663128. PubMed ID: 34150838
[No Abstract] [Full Text] [Related]
7. The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids.
Wei C; Li N; Shi B; Wang C; Wu Y; Lin T; Chen Y; Ge Y; Yu Y; Dong J
Int J Hyperthermia; 2022; 39(1):475-484. PubMed ID: 35271784
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence.
Liu Y; Wu X; Wu A; Gong C; Wang Z; Zhang L
Int J Hyperthermia; 2021; 38(1):1341-1348. PubMed ID: 34486914
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of ultrasound guided high intensity focused ultrasound ablation for patients with uterine fibroids classified by T2WI: a multicenter retrospective study.
Yuan Y; Xu W; Shen H; Lin Z; Xu F; Shi Q; Zhan P; Liu M; Shu J; Chen J; Xing HR
Int J Hyperthermia; 2023; 40(1):2212887. PubMed ID: 37202174
[TBL] [Abstract][Full Text] [Related]
10. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and efficacy of HIFU ablation for uterine fibroids NPVR ≥ 90%: a nested case-control study.
Gong X; Liu D; Yang MJ; Zhang R; Chen WZ; Chen JY
Int J Hyperthermia; 2022; 39(1):946-951. PubMed ID: 35853723
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study.
Marinova M; Ghaei S; Recker F; Tonguc T; Kaverina O; Savchenko O; Kravchenko D; Thudium M; Pieper CC; Egger EK; Mustea A; Attenberger U; Conrad R; Hadizadeh DR; Strunk H
Int J Hyperthermia; 2021 Sep; 38(2):30-38. PubMed ID: 34420447
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images.
Wang Y; Gong C; He M; Lin Z; Xu F; Peng S; Zhang L
Int J Hyperthermia; 2023; 40(1):2194594. PubMed ID: 37011910
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound guided high intensity focused ultrasound (USgHIFU) ablation for uterine fibroids: Do we need the microbubbles?
Orsi F; Monfardini L; Bonomo G; Krokidis M; Della Vigna P; Disalvatore D
Int J Hyperthermia; 2015 May; 31(3):233-9. PubMed ID: 25758436
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes.
Yang MJ; Yu RQ; Chen JY; Wang ZB
Front Oncol; 2021; 11():725193. PubMed ID: 34993130
[TBL] [Abstract][Full Text] [Related]
16. Long-term Efficacy of Fibroid Devascularization with Ultrasound-Guided High-Intensity Focused Ultrasound.
Zhou Y; Chen P; Ji X; Sun T; Li Y; Yuan J; Chen Y; Xiong Y; Wang Y
Acad Radiol; 2024 May; 31(5):1931-1939. PubMed ID: 37980220
[TBL] [Abstract][Full Text] [Related]
17. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a radiomics model based on T2-weighted imaging for predicting the efficacy of high intensity focused ultrasound ablation in uterine fibroids.
Cheng Y; Yang L; Wang Y; Kuang L; Pan X; Chen L; Cao X; Xu Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1803-1819. PubMed ID: 38415139
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.
Fan HJ; Cun JP; Zhao W; Huang JQ; Yi GF; Yao RH; Gao BL; Li XH
Int J Hyperthermia; 2018; 35(1):534-540. PubMed ID: 30428735
[TBL] [Abstract][Full Text] [Related]
20. Physician Experience in Technical Success of Achieving NPVR ≥ 80% of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids: A Multicenter Study.
Gong X; Zhang X; Liu D; Yang C; Zhang R; Xiao Z; Chen W; Chen J
Front Med Technol; 2021; 3():790956. PubMed ID: 35345412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]